CryoPort, Inc. short interest in 2025
In 2025, CryoPort, Inc.'s disclosed short interest ran from 3.98% of shares outstanding on 15 Jan 2025 to 5.91% on 31 Dec 2025, a change of +1.93 percentage points. The year's high was 7.48% on 14 Nov 2025 and its low 3.98% on 15 Jan 2025, averaging 5.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.34 days on 14 Feb 2025. Full history: CryoPort, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 3.98% (15 Jan 2025)
- End of year
- 5.91% (31 Dec 2025)
- Change
- +1.93 pp
- High
- 7.48% (14 Nov 2025)
- Low
- 3.98% (15 Jan 2025)
- Average
- 5.34%
- Highest days to cover
- 9.34 (14 Feb 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 3.98% | 6.46 | |
| 31 Jan 2025 | 4.06% | 8.31 | |
| 14 Feb 2025 | 4.21% | 9.34 | |
| 28 Feb 2025 | 4.14% | 7.41 | |
| 14 Mar 2025 | 4.51% | 2.67 | results (8-K), 10-K filed |
| 31 Mar 2025 | 4.94% | 4.31 | |
| 15 Apr 2025 | 5.25% | 5.00 | |
| 30 Apr 2025 | 5.28% | 6.23 | |
| 15 May 2025 | 5.45% | 5.43 | results (8-K), 10-Q filed |
| 30 May 2025 | 5.02% | 6.98 | |
| 13 Jun 2025 | 4.86% | 4.96 | |
| 30 Jun 2025 | 5.50% | 3.87 | |
| 15 Jul 2025 | 5.38% | 7.51 | |
| 31 Jul 2025 | 5.80% | 6.32 | |
| 15 Aug 2025 | 5.45% | 1.70 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 5.44% | 6.50 | |
| 15 Sep 2025 | 5.03% | 3.38 | |
| 30 Sep 2025 | 5.58% | 5.00 | |
| 15 Oct 2025 | 5.90% | 6.18 | |
| 31 Oct 2025 | 6.27% | 3.37 | |
| 14 Nov 2025 | 7.48% | 5.04 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 6.55% | 5.47 | |
| 15 Dec 2025 | 6.12% | 5.39 | |
| 31 Dec 2025 | 5.91% | 8.14 |
See also: CryoPort, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.